2049. Deputy Ken O'Flynn asked the Minister for Health whether the forthcoming national medicines disposal programme will include medicine-level cataloguing, reimbursement category tracking, estimated retail value assessment, or analysis of prescribing source; and if she will make a statement on the matter. [42486/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
2050. Deputy Ken O'Flynn asked the Minister for Health whether her Department or HSE has conducted any international benchmarking regarding medicines waste reduction strategies in comparable EU jurisdictions; and if so, to provide details. [42487/26]
2051. Deputy Ken O'Flynn asked the Minister for Health whether any estimate exists of medicines dispensed under State-funded schemes but not consumed due to non-adherence, therapy change, duplication, early discontinuation, death, hospital admission, or over-prescribing; and if she will make a statement on the matter. [42488/26]
2052. Deputy Ken O'Flynn asked the Minister for Health whether the HSE intends to publish annual reports arising from the new national medicines disposal programme, including estimated financial value and environmental impact of returned medicines. [42489/26]
2053. Deputy Ken O'Flynn asked the Minister for Health whether the proposed rare disease early-access framework will include formal eligibility criteria, maximum decision timelines, independent clinical oversight arrangements, and national equity safeguards; and if she will make a statement on the matter. [42490/26]
2054. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted any estimate of the potential annual cost exposure associated with a rare disease early-access framework; and if she will make a statement on the matter. [42491/26]
2055. Deputy Ken O'Flynn asked the Minister for Health whether any ethical or legal review has been conducted regarding prioritisation criteria within the proposed early-access framework for rare diseases; and if she will make a statement on the matter. [42492/26]
2056. Deputy Ken O'Flynn asked the Minister for Health whether patient registries or national prevalence datasets will form part of the planned rare disease reimbursement reforms; and if she will make a statement on the matter. [42493/26]
2057. Deputy Ruth Coppinger asked the Minister for Health the levels of staffing for community public health services in the Dublin 15 area; to report on whether all newborn children are receiving timely developmental checks; if all new parents are receiving their appropriate number of visits; and if she will make a statement on the matter. [42500/26]
2058. Deputy Ken O'Flynn asked the Minister for Health whether the absence of any national clinical audit relating to procedures funded under the Treatment Abroad Scheme since 2020 is considered acceptable from a patient-safety and governance perspective; and if she will make a statement on the matter. [42505/26]
2059. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any risk assessment regarding the absence of national clinical outcome auditing for procedures funded under the treatment abroad scheme; and if she will make a statement on the matter. [42506/26]
2060. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any mechanism to systematically monitor complication rates, revision procedures, adverse outcomes, readmissions, or long-term follow-up care requirements arising from procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42507/26]
2061. Deputy Ken O'Flynn asked the Minister for Health whether any national framework exists governing post-treatment outcome monitoring for patients returning to Ireland following procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42508/26]
2062. Deputy Ken O'Flynn asked the Minister for Health whether the HSE National Centre for Clinical Audit has ever been requested by her Department, the HSE, or the Treatment Abroad Scheme to consider conducting a national clinical audit relating to procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42509/26]
2063. Deputy Ken O'Flynn asked the Minister for Health whether any official within her Department or the HSE holds responsibility for assessing whether procedures funded under the Treatment Abroad Scheme should be subject to national clinical audit or outcome monitoring; and if she will make a statement on the matter. [42510/26]
2064. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any standardised national framework for measuring the effectiveness or value for money of agency-supported clinics, additional theatre sessions, diagnostics initiatives or insourcing arrangements; and if she will make a statement on the matter. [42512/26]
2065. Deputy Ken O'Flynn asked the Minister for Health whether regional performance and planning divisions use uniform metrics when monitoring waiting-list reduction initiatives; if so, to provide those metrics; and if she will make a statement on the matter. [42513/26]
2066. Deputy Ken O'Flynn asked the Minister for Health whether any comparative analysis has been undertaken between hospitals or regions regarding the cost-effectiveness of additional sessions or agency-supported waiting-list initiatives since 2020; and if she will make a statement on the matter. [42514/26]
2067. Deputy Ken O'Flynn asked the Minister for Health whether the HSE can identify the total number of waiting-list removals attributable specifically to insourcing, agency-supported clinics, weekend sessions or additional diagnostics capacity in each year from 2020 to 2026; and if she will make a statement on the matter. [42515/26]
2068. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General, Internal Audit, or any external body has assessed the governance, monitoring, or value-for-money arrangements relating to waiting-list reduction initiatives supported by agencies or third-party providers; and if she will make a statement on the matter. [42516/26]
2069. Deputy Ruth Coppinger asked the Minister for Health if a hospital appointment will be expedited for a person (details supplied); and if she will make a statement on the matter. [42535/26]
2070. Deputy Conor Sheehan asked the Minister for Health the number of vacant WTE posts in CAMHS eating disorder teams, broken down by CHO, in tabular form; and if she will make a statement on the matter. [42537/26]
2071. Deputy Conor Sheehan asked the Minister for Health when the MidWest CHO 3 will receive approval from her Department to establish an adult eating disorder team; and if she will make a statement on the matter. [42538/26]
2072. Deputy John McGuinness asked the Minister for Health the progress being made on the full implementation of the labour courts decision ref LCR 23185 of the 02/10/2025 relative to the terms of report 42; if former employees referenced in this decision have been paid; if not, when is this likely to happen; and if she will make a statement on the matter. [42542/26]
2073. Deputy Eoin Hayes asked the Minister for Health for an update on the plans and progress to relocate the National Maternity Hospital from Holles St. Dublin 2 to the site at St. Vincent's Hospital in Dublin 4; and if she will make a statement on the matter. [42564/26]